English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
The New England Journal of Medicine
Bob Pepalis
| Jun 3, 2020
Flawed data puts COVID-19 policies, treatments in doubt
Amanda Rupp
| May 16, 2016
Takeda Pharmaceutical publishes Ninlaro trial results
Trending
+
Regulatory
Patient Daily News Service
| Jan 12, 2025
National Consumers League CEO: Federal 340b drug discount program ‘hijacked by hospitals and contract pharmacies’
+
Regulatory
Patient Daily News Service
| Jan 16, 2025
FTC Chair: Report Finds 'Three Major Pharmacy Benefit Managers Hiked Costs for a Wide Range of Lifesaving Drugs, Including Medications to Treat Heart Disease and Cancer'
+
Pharmaceuticals
Patient Daily
| Jan 15, 2025
Dr. Peter Hotez receives 2025 Hill Prize for public health innovations
+
Regulatory
Patient Daily reports
| Jan 14, 2025
National health reform group: 'Plenty of evidence that hospitals are not passing along' discounted drug prices under 340b program
